Deutsch English Français

Contact

EP2934479

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2934479

EP2934479 - CICLESONIDE FOR THE TREATMENT OF AIRWAY DISEASE IN HORSES [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 26.07.2019 Database last updated on 02.07.2024
Former	The patent has been granted Status updated on 17.08.2018
Former	Grant of patent is intended Status updated on 07.05.2018
Former	Examination is in progress Status updated on 16.12.2016
Most recent event Tooltip	26.07.2019	No opposition filed within time limit	published on 28.08.2019 [2019/35]
Applicant(s)	For all designated states Boehringer Ingelheim Vetmedica GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE
	[2018/38]
Former [2015/44]	For all designated states Boehringer Ingelheim Vetmedica GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE
Inventor(s)	01 / ALBRECHT, Balazs Boehringer Ingelheim GmbH Corporate Patents Binger Straße 173 55216 Ingelheim am Rhein / DE
	02 / AVEN, Michael Boehringer Ingelheim GmbH Corporate Patents Binger Straße 173 55216 Ingelheim am Rhein / DE
	03 / LAMAR, Janine Boehringer Ingelheim GmbH Corporate Patents Binger Straße 173 55216 Ingelheim am Rhein / DE
	04 / LANG, Ingo Boehringer Ingelheim GmbH Corporate Patents Binger Straße 173 55216 Ingelheim am Rhein / DE
	[2018/38]
Former [2015/44]	01 / ALBRECHT, Balazs Boehringer Ingelheim GmbH Corporate Patents Binger Straße 173 55216 Ingelheim Am Rhein / DE
	02 / AVEN, Michael Boehringer Ingelheim GmbH Corporate Patents Binger Straße 173 55216 Ingelheim Am Rhein / DE
	03 / LAMAR, Janine Boehringer Ingelheim GmbH Corporate Patents Binger Straße 173 55216 Ingelheim Am Rhein / DE
	04 / LANG, Ingo Boehringer Ingelheim GmbH Corporate Patents Binger Straße 173 55216 Ingelheim Am Rhein / DE
Representative(s)	Simon, Elke Anna Maria, et al Boehringer Ingelheim GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE
	[2015/44]
Application number, filing date	13811924.3	18.12.2013
	[2015/44]
	WO2013EP77265
Priority number, date	EP20120199302	21.12.2012 Original published format: EP 12199302
	[2015/44]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2014096115
	Date:	26.06.2014
	Language:	EN
	[2014/26]
	Type:	A1 Application with search report
	No.:	EP2934479
	Date:	28.10.2015
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 26.06.2014 takes the place of the publication of the European patent application.
	[2015/44]
	Type:	B1 Patent specification
	No.:	EP2934479
	Date:	19.09.2018
	Language:	EN
	[2018/38]
Search report(s)	International search report - published on:	EP	26.06.2014
Classification	IPC:	A61K31/58, A61K31/573, A61K9/00, A61P11/00	[2018/21]
	CPC:	A61K31/58 (EP,US); A61K9/0073 (EP,US); A61K9/0078 (EP,US); A61K9/008 (US); A61P11/00 (EP)
	Former IPC [2015/44]	A61K9/00, A61K31/573, A61P11/00
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/44]
Extension states	BA	Not yet paid
	ME	Not yet paid
Title	German:	CICLESONIDE FÜR DIE BEHANDLUNG VON ATEMWEGSERKRANKUNGEN BEI PFERDEN	[2018/22]
	English:	CICLESONIDE FOR THE TREATMENT OF AIRWAY DISEASE IN HORSES	[2015/44]
	French:	CICLÉSONIDE POUR LE TRAITEMENT DE MALADIES DES VOIES RESPIRATOIRES CHEZ LES CHEVAUX	[2018/21]
	Former [2015/44]	CICLESONID ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN BEI PFERDEN
	Former [2015/44]	CICLÉSONIDE POUR LE TRAITEMENT D'UNE MALADIE DES VOIES RESPIRATOIRES CHEZ LES CHEVAUX
Entry into regional phase	21.07.2015	National basic fee paid
	21.07.2015	Designation fee(s) paid
	21.07.2015	Examination fee paid
Examination procedure	21.07.2015	Examination requested [2015/44]
	15.02.2016	Amendment by applicant (claims and/or description)
	24.08.2016	Despatch of a communication from the examining division (Time limit: M06)
	27.02.2017	Reply to a communication from the examining division
	19.12.2017	Despatch of a communication from the examining division (Time limit: M02)
	15.02.2018	Reply to a communication from the examining division
	08.05.2018	Communication of intention to grant the patent
	13.08.2018	Fee for grant paid
	13.08.2018	Fee for publishing/printing paid
	13.08.2018	Receipt of the translation of the claim(s)
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.08.2016
Opposition(s)	20.06.2019	No opposition filed within time limit [2019/35]
Fees paid	Renewal fee
	04.01.2016	Renewal fee patent year 03
	02.01.2017	Renewal fee patent year 04
	02.01.2018	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	SM	19.09.2018
	[2019/27]
Cited in	International search	[Y]US2007117783 (BRUECK-SCHEFFLER ANTJE [DE]) [Y] 1-15 * paragraph [0066]; claim 1 *;
		[Y]US2008041370 (RADAU KIRSTEN [DE], et al) [Y] 5-15* claims 28, 32 *;
		[Y] - J. DAUVILLIER ET AL, "Effect of Long-Term Fluticasone Treatment on Immune Function in Horses with Heaves", JOURNAL OF VETERINARY INTERNAL MEDICINE, (20110501), vol. 25, no. 3, doi:10.1111/j.1939-1676.2011.0717.x, ISSN 0891-6640, pages 549 - 557, XP055057584 [Y] 1-15 * abstract * DOI: http://dx.doi.org/10.1111/j.1939-1676.2011.0717.x
		[Y] - DIETZEL K ET AL, "Ciclesonide: An on-site-activated steroid ( New drugs for Asthma, Allerg and COPD.)", PROGRESS IN RESPIRATORY RESEARCH, KARGER, BASEL, CH, (20010101), vol. 31, ISSN 1422-2140, pages 91 - 93, XP008089200 [Y] 1-15 * abstract *
	Examination	- Fei, "SUBSTANCE ACTIVITY BANNED SUBSTANCES", (20110404), URL: http://babh.government.bg/uploads/File/Za_biznesa/VMP/2011_Equine_Prohibited_List.pdf, (20160817), XP055296090

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p